Franchina, M.; Pizzimenti, C.; Fiorentino, V.; Martini, M.; Ricciardi, G.R.R.; Silvestris, N.; Ieni, A.; Tuccari, G.
Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes. Int. J. Mol. Sci. 2023, 24, 12795.
https://doi.org/10.3390/ijms241612795
AMA Style
Franchina M, Pizzimenti C, Fiorentino V, Martini M, Ricciardi GRR, Silvestris N, Ieni A, Tuccari G.
Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes. International Journal of Molecular Sciences. 2023; 24(16):12795.
https://doi.org/10.3390/ijms241612795
Chicago/Turabian Style
Franchina, Mariausilia, Cristina Pizzimenti, Vincenzo Fiorentino, Maurizio Martini, Giuseppina Rosaria Rita Ricciardi, Nicola Silvestris, Antonio Ieni, and Giovanni Tuccari.
2023. "Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes" International Journal of Molecular Sciences 24, no. 16: 12795.
https://doi.org/10.3390/ijms241612795
APA Style
Franchina, M., Pizzimenti, C., Fiorentino, V., Martini, M., Ricciardi, G. R. R., Silvestris, N., Ieni, A., & Tuccari, G.
(2023). Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes. International Journal of Molecular Sciences, 24(16), 12795.
https://doi.org/10.3390/ijms241612795